Physician profile
Ishmeet Singh
NPI 1336306406
$6,408.65
in general payments reported to CMS, 2019-2025
13 companies · $48.96 in 2025
The $48.96 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $73.53 · 2021: $5,196 · 2022: $346 · 2023: $20.15 · 2024: $30.95 · 2025: $48.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,708.70 | 2020-2022 | |
| Merz North America, INC. | $618.05 | 2019-2022 | |
| Abbott Laboratories | $438.07 | 2021-2022 | |
| Nevro Corp. | $255.74 | 2019-2021 | |
| Medtronic, INC. | $99.79 | 2021-2025 | Intellis Adaptivestim |
| Abbvie INC. | $75.87 | 2023-2025 | |
| Pfizer INC. | $62.38 | 2019 | |
| Si-Bone, INC. | $39.13 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $37.64 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $23.30 | 2019 | |
| Boston Scientific Corporation | $20.06 | 2019 | |
| Daiichi Sankyo INC. | $17.91 | 2019 | |
| Medtronic USA, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishmeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.